Graphite Bio Inc
GRPH
Get informed when a big investor buys or sells
+ FollowMarket Cap$185.19M
Close$
$3.25
2.3% upside
Current Fair Value
2.3% upsideUndervalued by 2.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $185.19 Million |
|---|---|
| Enterprise Value | $160.66 Million |
| Dividend Yield | $2.06 (-) |
| Earnings per Share | $-2.85 |
| Beta | 0.2 |
| Outstanding Shares | 31,352,702 |
Return
| Return on Equity | -44.22% |
|---|---|
| Return on Assets | -39.99% |
| Return on Invested Capital | -47.96% |
Valuation & Multiples
| P/E Ratio | -2.24 |
|---|---|
| PEG | -1.22 |
| Price to Sales | - |
| Price to Book Ratio | 0.45 |
| Enterprise Value to Revenue | 7.65 |
| Enterprise Value to EBIT | -1.36 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 11, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Graphite Bio Inc
27 employees